Name: UMIN ID:
Unique ID issued by UMIN | UMIN000035692 |
---|---|
Receipt number | R000040620 |
Scientific Title | Research on the blood concentration of ponatinib and treatment outcome in patients with chronic phase chronic myelogenous leukemia (CP-CML) |
Date of disclosure of the study information | 2019/02/01 |
Last modified on | 2024/02/07 14:07:56 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/01/28 10:56:17 | ||
2 | Update | 2019/03/19 17:39:46 | Recruitment status Date of IRB |
|
3 | Update | 2021/01/29 13:10:14 | Last follow-up date |
|
4 | Update | 2021/08/03 14:52:34 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2021/08/03 14:56:50 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Institutions |
|
6 | Update | 2021/08/03 14:57:43 | Last follow-up date |
|
7 | Update | 2022/02/01 06:32:01 | Recruitment status Last follow-up date Date trial data considered complete Date analysis concluded |
|
8 | Update | 2024/02/07 14:07:56 | Recruitment status Date analysis concluded |